Standard BioTools Reports Third Quarter 2024 Financial Results - Standard BioTools ( NASDAQ:LAB )
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 ( GLOBE NEWSWIRE ) -- Standard BioTools Inc. LAB ( the "Company" ) today announced unaudited interim financial results for the third quarter ended September 30, 2024. Reported third quarter 2024 revenue of $45 million
| Ticker |
Sentiment |
Impact |
|
LAB
|
Somewhat Bullish
|
22 %
|
|
ILMN
|
Neutral
|
2 %
|
|
SLGC
|
Neutral
|
16 %
|
